Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabela Lens

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Alimentary Pharmacology & Therapeutics|May 2, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvirJuan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
Journal of Clinical Microbiology|November 8, 2014
High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methodsJosep Quer, Josep Gregori, Francisco Rodríguez-Frias, et al.
Digestive Diseases and Sciences|February 3, 2023
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis BBeatriz Mateos-Muñoz, María Buti, Inmaculada Fernández Vázquez, et al.
Gastroenterologia Y Hepatologia|May 9, 2024
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)Edilmar Alvarado-Tapias, Douglas Maya-Miles, Agustin Albillos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2025
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis BMaria Kalafateli, Roberta Forlano, Eleanor Barnes, et al.
Journal of Clinical Microbiology|June 26, 2016
Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current MethodsJosep Quer, Josep Gregori, Francisco Rodríguez-Frias, et al.
Nature|January 25, 2023
Tissue CD14<sup>+</sup>CD8<sup>+</sup> T cells reprogrammed by myeloid cells and modulated by LPSLaura J Pallett, Leo Swadling, Mariana Diniz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 24, 2021
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral DiseaseOctavi Bassegoda, Pol Olivas, Laura Turco, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Incidence and Clinical Significance of Recompensation After HCV CureGeorg Semmler, Sabela Lens, Álvaro Hidalgo, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Alimentary Pharmacology & Therapeutics|May 2, 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvirJuan Carlos Ruiz-Cobo, Jordi Llaneras, Xavier Forns, et al.
Journal of Hepatology|April 1, 2026
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohortEdo Dongelmans, Grishma Hirode, Florian van Bӧmmel, et al.
Journal of Clinical Microbiology|November 8, 2014
High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methodsJosep Quer, Josep Gregori, Francisco Rodríguez-Frias, et al.
Digestive Diseases and Sciences|February 3, 2023
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis BBeatriz Mateos-Muñoz, María Buti, Inmaculada Fernández Vázquez, et al.
Gastroenterologia Y Hepatologia|May 9, 2024
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)Edilmar Alvarado-Tapias, Douglas Maya-Miles, Agustin Albillos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2025
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis BMaria Kalafateli, Roberta Forlano, Eleanor Barnes, et al.
Journal of Clinical Microbiology|June 26, 2016
Correction for Quer at al., High-Resolution Hepatitis C Virus Subtyping Using NS5B Deep Sequencing and Phylogeny, an Alternative to Current MethodsJosep Quer, Josep Gregori, Francisco Rodríguez-Frias, et al.
Nature|January 25, 2023
Tissue CD14<sup>+</sup>CD8<sup>+</sup> T cells reprogrammed by myeloid cells and modulated by LPSLaura J Pallett, Leo Swadling, Mariana Diniz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 24, 2021
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral DiseaseOctavi Bassegoda, Pol Olivas, Laura Turco, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Incidence and Clinical Significance of Recompensation After HCV CureGeorg Semmler, Sabela Lens, Álvaro Hidalgo, et al.
Pageof 17